Barbara Hero
University of Cologne · 343 works · 15,428 citations · h-index 63
Top works
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- Neuroblastoma Screening at One Year of Age
- Metabolic activity and clinical features of primary ganglioneuromas
- Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
- Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- Neuroblastoma: biology and molecular and chromosomal pathology
- Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- Neuroblastoma
- Consolidation Treatment With Chimeric Anti-GD2-Antibody ch14.18 in Children Older Than 1 Year With Metastatic Neuroblastoma
- Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
- Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
- Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
- Childhood cancer predisposition syndromes—A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology
- Mutational dynamics between primary and relapse neuroblastomas
- Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial
- The Tumor-Associated Antigen PRAME Is Universally Expressed in High-Stage Neuroblastoma and Associated with Poor Outcome